Publications by authors named "Cor H Lamers"

Claim this Profile
I
Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation.
Lucia E Duinhouwer, Nick Beije, Bronno van der Holt, Anita Rijken-Schelen, Cor H Lamers

Bone Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients.
Yarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, Reno Debets, Cor H J Lamers

Front Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.
Cor H J Lamers, Rebecca Wijers, Cornelis A M van Bergen, Judith A E Somers, Eric Braakman

Blood· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview.
Cor H J Lamers, Yarne Klaver, Jan W Gratama, Stefan Sleijfer, Reno Debets

Biochem Soc Trans· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive T-cell therapy: a need for standard immune monitoring.
Yarne Klaver, Andre Kunert, Stefan Sleijfer, Reno Debets, Cor H J Lamers

Immunotherapy· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
Cor H J Lamers, Sabine van Steenbergen-Langeveld, Mandy van Brakel, Corrien M Groot-van Ruijven, Pascal M M L van Elzakker

Hum Gene Ther Methods· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of RGB-286638, a novel, multitargeted cyclin-dependent kinase inhibitor in patients with solid tumors.
Diane A J van der Biessen, Herman Burger, Peter de Bruijn, Cor H J Lamers, Nicole Naus

Clin Cancer Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically modified T lymphocytes: more than just direct effectors.
Cor H J Lamers, Reno Debets

Immunotherapy· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells.
Cor H J Lamers, Pascal van Elzakker, Sabine C L van Steenbergen, Barbara A Luider, Corrien Groot

Cytotherapy· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.
Cor Hj Lamers, Stefan Sleijfer, Sabine van Steenbergen, Pascal van Elzakker, Brigitte van Krimpen

Mol Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study.
Pleun J de Raaf, Stefan Sleijfer, Cor H J Lamers, Agnes Jager, Jan Willem Gratama

Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.
Adriaan H C de Jongste, Marieke T de Graaf, Emanuela Martinuzzi, Patricia D M van den Broek, Jaco Kraan, Cor H J Lamers

Neuro Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells.
Cor H J Lamers, Ralph Willemsen, Pascal van Elzakker, Sabine van Steenbergen-Langeveld, Marieke Broertjes

Blood· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials.
Jeremy L Davis, Marc R Theoret, Zhili Zheng, Cor H J Lamers, Steven A Rosenberg

Clin Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of circulating endothelial cells in normotensive and severe preeclamptic pregnancies.
Michiel H Strijbos, Claudia A Snijder, Jaco Kraan, Cor H J Lamers, Jan W Gratama

Cytometry B Clin Cytom· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells.
Michiel H Strijbos, Brigitte A van Krimpen, Reno Debets, Jaco Kraan, Stefan Sleijfer, Cor H J Lamers

Thromb Haemost· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of circulating endothelial cells by flow cytometry.
Michiel H Strijbos, Jaco Kraan, Cor H J Lamers, Stefan Sleijfer, Jan W Gratama

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Cor H J Lamers, Ralph A Willemsen, Pascal M M L van Elzakker, Jan Willem Gratama, Reno Debets

J Immunother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.
Janet W de Beukelaar, Johannes C Milikan, Georges M Verjans, Marieke T de Graaf, Yvette van Norden, Cor H Lamers

J Neurol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage.
Michiel H Strijbos, Chandra Rao, Paul I M Schmitz, Jaco Kraan, Cor H Lamers

Thromb Haemost· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo.
Cor H J Lamers, Sabine C L Langeveld, Corrien M Groot-van Ruijven, Reno Debets, Stefan Sleijfer

Cancer Immunol Immunother· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
Cor H J Lamers, Stefan Sleijfer, Arnold G Vulto, Wim H J Kruit, Mike Kliffen

J Clin Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant.
Johanna E A Portielje, Wim H J Kruit, Anke J M Eerenberg, Martin Schuler, Alex Sparreboom, Cor H J Lamers

Cancer Immunol Immunother· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors.
Valérie Vantomme, Christine Dantinne, Noreddine Amrani, Philippe Permanne, Dirk Gheysen, Cor H J Lamers

J Immunother· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.
Johanna E A Portielje, Cor H J Lamers, Wim H J Kruit, Alex Sparreboom, Reinder L H Bolhuis

Clin Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis